Novavax AB
556549-4019ActiveInnovating vaccines using proprietary technology platform and strategic partnerships.
Oversikt
- 100–199
- Ansatte
- 500–1000mill SEK
- Omsetning
- 1997
- Grunnlagt
Nøkkelbeslutningstakere
Rick Crowley
Executive Vice President, Chief Operations Officer
Jane Shershenovich
Vice President, Chief Intellectual Property Counsel, Legal
Jim Kelly
Executive Vice President, Chief Financial Officer and Treasurer
Elaine O’Hara
Executive Vice President, Chief Strategy Officer
+18 flere kontakter i Funnelfeedr
Beskrivelse
Novavax is a company dedicated to developing life-saving vaccine innovations to prevent serious illness and eradicate disease globally. They leverage a proprietary, cutting-edge technology platform featuring recombinant protein-based nanoparticles and their specialized Matrix-M® adjuvant. This platf...
Tagger
Nøkkelord
Teknologier i bruk
Bedriftsinformasjon
- Bransje
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Juridisk form
- Aktiebolag
- MVA-nummer
- SE556549401901
Beslutningstakere
22 kontakter i FunnelfeedrRick Crowley
Executive Vice President, Chief Operations Officer
Jane Shershenovich
Vice President, Chief Intellectual Property Counsel, Legal
Jim Kelly
Executive Vice President, Chief Financial Officer and Treasurer
Elaine O’Hara
Executive Vice President, Chief Strategy Officer
Rachel King
Director
Ian Watkins
Executive Vice President, Chief Human Resources Officer
David Mott
Director
Gretchen Earle
Senior Director, Global Program Management
Rick Rodgers, MBA
Director
Robert Walker, MD
Senior Vice President, Chief Medical Officer
Ruxandra Draghia-Akli, MD, PhD
Executive Vice President, Head of Research & Development
Richard Douglas, PhD
Director
Margaret G. McGlynn, R. Ph.
Chairman of the Board of Directors
Silvia Taylor
Executive Vice President, Chief Corporate Affairs Officer and Head of Novavax Sweden
Troy Morgan, JD
Senior Vice President Deputy General Counsel & Chief Compliance Officer
Gregg Alton
Director
Mark Casey
Executive Vice President, Chief Legal Officer
John Shiver, PhD
Director
Charles Newton
Director
John C. Jacobs
President and Chief Executive Officer
Kumar Singh Saikatendu
Head of Translational Medicine team
Henrietta Ukwu, MD
Executive Vice President, Chief Regulatory Officer
Lignende bedrifter
20 lignende bedrifter i Funnelfeedr
VALNEVA SWEDEN AB
Specialty vaccine company developing, manufacturing, and commercializing prophylactic vaccines.
Bavarian Nordic Sweden AB
1–4 ansattePioneering global developer and manufacturer of life-saving vaccines.
Abera Bioscience AB
Developing next-generation nasal vaccines using modular OMV platform technology.
ARGENX BV
1–4 ansatteEngineering life-changing immunology solutions for severe autoimmune diseases.
VACARA AB
2 ansatteSwedish biotech developing RA diagnostics, vaccines, and therapeutics.
Utforsk mer
Spørsmål om Novavax AB
Vil du se Funnelfeedr i aksjon?
Book en gratis demo og oppdag hvordan Funnelfeedr hjelper deg med å finne og konvertere dine ideelle kunder.
Book en demo